Leukemia: all 5,475 studies
Page 35 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic LeukemiaCompletedNCT02036489Phase 4
- Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)Status unknownNCT02034656
- Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid LeukemiaTerminatedNCT02034227Phase 1/2
- Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT02029950Phase 1
- Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched TransplantationCompletedNCT02028650
- IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)WithdrawnNCT02028039Phase 2
- AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine ChemotherapyStatus unknownNCT02024308Phase 4
- Evaluation of Splenic Irradiation in Chronic Lymphatic LeukemiaWithdrawnNCT02020109
- Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.CompletedNCT02017457Phase 2
- Development of Immunological Assays for the Evaluation of Tumor Antigen Specific ImmunityCompletedNCT02016833
- A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid LeukemiaCompletedNCT02016729Phase 1
- Ruxolitinib in the Treatment of Chronic Lymphocytic LeukemiaCompletedNCT02015208Phase 1/2
- Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)CompletedNCT02013648Phase 3
- Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia PatientsCompletedNCT02010931
- Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single VaccinationStatus unknownNCT02007811Phase 1/2
- Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic LeukemiaCompletedNCT02003612
- Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid LeukaemiaCompletedNCT02001818Phase 2
- Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain TumorsWithdrawnNCT02000986Not applicable
- LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous LeukemiaCompletedNCT01999556
- Pilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger PatientsCompletedNCT01999413Phase 2
- Targeted High Throughput Sequencing in the Diagnosis of Pediatric Acute LeukemiaCompletedNCT01991249Not applicable
- A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.CompletedNCT01991184Phase 1
- Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic LeukemiaStatus unknownNCT01990807Phase 4
- Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APLStatus unknownNCT01987297Phase 4
- Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic LeukemiaSuspendedNCT01982175Phase 2
- Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)Status unknownNCT01976520Phase 1
- Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes LeukemiaCompletedNCT01976182Phase 2
- Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic LeukemiaSuspendedNCT01974479Phase 1
- Observational Study of Patients Older Than 60 Years With Acute Myeloblastic LeukemiaStatus unknownNCT01966497
- Transfusional Iron Overload Among Leukemia SurvivorsCompletedNCT01965171
- Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01961765Phase 1
- Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell TransplantCompletedNCT01959477Early Phase 1
- Clinical Study of DC Plus CIK for Patients With Relapse Acute Leukemia After Allo-HSCTStatus unknownNCT01956630Phase 1/2
- AZD6738 First Time in Patient Multiple Ascending Dose StudyCompletedNCT01955668Phase 1
- Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008Status unknownNCT01953770Not applicable
- Proteasome Inhibition in Acute Promyelocytic LeukemiaStatus unknownNCT01950611Phase 2
- Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden.CompletedNCT01950286
- Haploidentical NK-cell Infusion in Acute Myeloid LeukemiaCompletedNCT01947322Phase 1/2
- Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and LymphomaTerminatedNCT01944982Phase 1/2
- Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic LeukemiaTerminatedNCT01944943Phase 2
- Safety Study of CPX-351 in Children With Relapsed Leukemia or LymphomaCompletedNCT01943682Phase 1
- High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic TransplantCompletedNCT01941680
- Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular ResponseCompletedNCT01933906Phase 1
- A Feasibility Study of Prophylactic White Blood Cell TransfusionsCompletedNCT01932710Phase 2
- Phase II Part 2 Expansion of Oral Rigosertib in Combination With AzacitidineCompletedNCT01926587Phase 1/2
- A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic LeukemiaActive, not recruitingNCT01920737Phase 2
- Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-LeukemiaCompletedNCT01914484Phase 1/2
- N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia SurvivorsCompletedNCT01913093
- Long-Term Quality of Life in Patients With Acute Promyelocytic LeukemiaCompletedNCT01910623
- L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBLTerminatedNCT01910428Phase 1
- PH 2 ADI-PEG 20 Acute Myeloid LeukemiaCompletedNCT01910012Phase 2
- Phase 1 Study of CC-486 in Japanese Subjects With Hematological NeoplasmsTerminatedNCT01908387Phase 1
- Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral LiquidStatus unknownNCT01906671Phase 4
- Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT01904643Phase 1
- A Safety Study of SGN-CD33A in AML PatientsCompletedNCT01902329Phase 1
- Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In RemissionStatus unknownNCT01901666Phase 4
- ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia PatientsCompletedNCT01901367Not applicable
- Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALLCompletedNCT01896752
- Pneumococcal Vaccine in Untreated CLL PatientsCompletedNCT01892618Phase 3
- Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)TerminatedNCT01891981Phase 1
- Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia PatientsStatus unknownNCT01889407
- Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS TrialStatus unknownNCT01887561Phase 2
- Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01886859Phase 1
- The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic LeukemiaCompletedNCT01886651
- TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaStatus unknownNCT01883219Phase 2
- HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALLStatus unknownNCT01873807Phase 4
- Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic PhaseCompletedNCT01872442Phase 2
- Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesCompletedNCT01871675Phase 1
- Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic LeukemiaApproved for marketingNCT01869803
- Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33Status unknownNCT01864902Phase 1/2
- Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19Status unknownNCT01864889Not applicable
- TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet StudyCompletedNCT01860456
- P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic MalignanciesCompletedNCT01854567Phase 3
- Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic LeukemiaStatus unknownNCT01849939Phase 2
- Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid LeukemiaCompletedNCT01843634Early Phase 1
- Sulindac for Patients With AMLWithdrawnNCT01843179Phase 2
- Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute LeukemiaCompletedNCT01842672Phase 1/2
- Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete RemissionCompletedNCT01842139Phase 1
- Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid LeukemiaCompletedNCT01839240Phase 1
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWithdrawnNCT01835288Phase 2
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaCompletedNCT01834248Phase 1
- BR in Patients With CLL With Comorbidities and/or Renal DysfunctionCompletedNCT01832922Phase 1
- Brentuximab Vedotin + Re-induction Chemotherapy for AMLCompletedNCT01830777Phase 1
- Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 YearsStatus unknownNCT01828489Phase 3
- Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell TransplantCompletedNCT01822509Phase 1
- Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01822015Early Phase 1
- Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01820624Phase 1
- Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related AplasiaCompletedNCT01819792Phase 4
- Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid HemopathyCompletedNCT01819558Phase 1/2
- Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment IntoleranceCompletedNCT01819389Phase 3
- A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute LeukemiaCompletedNCT01814488Phase 2
- Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCTCompletedNCT01810120Phase 1/2
- Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic TransplantationCompletedNCT01809847Phase 2
- Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeStatus unknownNCT01809392Phase 2/3
- Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell TransplantationStatus unknownNCT01806116Phase 4
- Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid LeukemiaCompletedNCT01805843
- De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid LeukaemiaCompletedNCT01804985Phase 2
- Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic PhaseStatus unknownNCT01802450Phase 2
- Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid LeukemiaTerminatedNCT01801046Phase 1
- Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell TransplantationStatus unknownNCT01800643Phase 2/3